Prelude Therapeutics Inc(PRLD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PRLD Prelude Therapeutics Inc

交易中 12-16 14:20:01 EST

2.01

+0.07

+3.35%

最高2.06	最低1.79	成交量88.84万
今开1.90	昨收1.94	日振幅13.92%
总市值1.26亿	流通市值501.73万	总股本6,287万
成交额168.29万	换手率35.50%	流通股本250.24万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PRLD","market":"US","secType":"STK","nameCN":"Prelude Therapeutics Inc","latestPrice":2.005,"timestamp":1765912681875,"preClose":1.94,"halted":0,"volume":888409,"delay":0,"floatShares":2502400,"shares":62865300,"eps":-1.637348,"marketStatus":"交易中","change":0.065,"latestTime":"12-16 14:20:01 EST","open":1.9,"high":2.06,"low":1.79,"amount":1682851.6907972002,"amplitude":0.139175,"askPrice":2.01,"askSize":300,"bidPrice":2,"bidSize":32,"shortable":3,"etf":0,"ttmEps":-1.637348,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765918800000},"marketStatusCode":2,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":1.94,"preHourTrading":{"tag":"盘前","latestPrice":1.95,"preClose":1.94,"latestTime":"09:18 EST","volume":6059,"amount":11851.3870348,"timestamp":1765894723871},"postHourTrading":{"tag":"盘后","latestPrice":1.9387,"preClose":1.94,"latestTime":"19:59 EST","volume":7690,"amount":14781.5563,"timestamp":1765846765344},"volumeRatio":2.403705,"impliedVol":1.6816,"impliedVolPercentile":0.96},"requestUrl":"/m/hq/s/PRLD","defaultTab":"news","newsList":[{"id":"1190878048","title":"Prelude Therapeutics申请不时重新销售最多630万股投票普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1190878048","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190878048?lang=zh_cn&edition=full","pubTime":"2025-12-11 05:20","pubTimestamp":1765401636,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics申请不时重新销售最多630万股投票普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRLD","BK4505"],"gpt_icon":0},{"id":"1198838550","title":"Prelude Therapeutics与因塞特医疗签署独家选择权协议以推进选择性Jak2v617f Jh2抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1198838550","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198838550?lang=zh_cn&edition=full","pubTime":"2025-11-04 20:03","pubTimestamp":1762257795,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics与因塞特医疗签署独家选择权协议，以推动选择性Mutant Selective Jak2v617f Jh2抑制剂的研发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","PRLD","BK4139","BK4505","BK4585","BK4588","BK4532","BK4550"],"gpt_icon":0},{"id":"2555461054","title":"Prelude Therapeutics Incorporated盘中异动 股价大涨17.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555461054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555461054?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:38","pubTimestamp":1753796281,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时38分，Prelude Therapeutics Incorporated股票出现波动，股价快速上涨17.31%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.13%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213801a469ca1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729213801a469ca1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRLD","BK4007","BK4505","LENZ","BK4539"],"gpt_icon":0},{"id":"1109922758","title":"Prelude Therapeutics公司全年销售额为700万美元，超过预期的200万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1109922758","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109922758?lang=zh_cn&edition=full","pubTime":"2025-03-10 19:48","pubTimestamp":1741607320,"startTime":"0","endTime":"0","summary":"Prelude Therapeutics (NASDAQ:PRLD) 报告称其季度销售额为700万美元，超出分析师一致预期的200万美元，超出幅度达250.00%。以上内容来自Benzinga Earnings专栏，原文如下：Prelude $Therapeutics(LENZ)$ (NASDAQ:PRLD) reported quarterly sales of $7.000 million which beat the analyst consensus estimate of $2.000 million by 250.00 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRLD","LENZ"],"gpt_icon":0},{"id":"2517719648","title":"Prelude Therapeutics Incorporated盘中异动 下午盘急速下挫5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517719648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517719648?lang=zh_cn&edition=full","pubTime":"2025-03-07 02:12","pubTimestamp":1741284753,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日02时12分，Prelude Therapeutics Incorporated股票出现异动，股价快速下挫5.70%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.87%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307021234abebacec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307021234abebacec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","PRLD","BK4139"],"gpt_icon":0},{"id":"2512431534","title":"Prelude Therapeutics Incorporated盘中异动 临近收盘大幅跳水5.14%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512431534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512431534?lang=zh_cn&edition=full","pubTime":"2025-02-20 04:43","pubTimestamp":1739997821,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日04时43分，Prelude Therapeutics Incorporated股票出现异动，股价快速下跌5.14%。截至发稿，该股报0.900美元/股，成交量11.2076万股，换手率0.20%，振幅7.39%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.81%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220044341a24c3d57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220044341a24c3d57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4505","PRLD"],"gpt_icon":0},{"id":"2511694852","title":"Prelude Therapeutics Incorporated盘中异动 快速拉升5.26%报1.000美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511694852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511694852?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:11","pubTimestamp":1739545861,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时11分，Prelude Therapeutics Incorporated股票出现异动，股价急速拉升5.26%。截至发稿，该股报1.000美元/股，成交量3.2235万股，换手率0.06%，振幅5.79%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.05%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231101962324b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231101962324b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","PRLD","BK4139","LENZ"],"gpt_icon":0},{"id":"2511525030","title":"Prelude Therapeutics Incorporated盘中异动 股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525030","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511525030?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457066,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Prelude Therapeutics Incorporated股票出现异动，股价急速拉升5.40%。截至发稿，该股报0.955美元/股，成交量1429股，换手率0.00%，振幅0.83%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.01%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223107abcdb1e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223107abcdb1e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","BK4139","PRLD"],"gpt_icon":0},{"id":"2510380548","title":"Prelude Therapeutics Incorporated盘中异动 早盘股价大跌6.42%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380548?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:36","pubTimestamp":1739284603,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时36分，Prelude Therapeutics Incorporated股票出现异动，股价快速跳水6.42%。截至发稿，该股报1.02美元/股，成交量8807股，换手率0.02%，振幅5.50%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.93%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223643961f489e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223643961f489e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4139","BK4505","LENZ"],"gpt_icon":0},{"id":"2510890334","title":"Prelude Therapeutics Incorporated盘中异动 快速拉升5.94%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510890334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510890334?lang=zh_cn&edition=full","pubTime":"2025-02-11 04:53","pubTimestamp":1739220793,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日04时53分，Prelude Therapeutics Incorporated股票出现异动，股价急速拉升5.94%。截至发稿，该股报1.07美元/股，成交量16.2728万股，换手率0.30%，振幅7.91%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.96%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211045313961e46a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211045313961e46a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4505","PRLD"],"gpt_icon":0},{"id":"2509724663","title":"Prelude Therapeutics Incorporated盘中异动 大幅下挫5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509724663","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509724663?lang=zh_cn&edition=full","pubTime":"2025-02-08 01:19","pubTimestamp":1738948777,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日01时19分，Prelude Therapeutics Incorporated股票出现异动，股价急速跳水5.41%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.59%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208011937abc64f39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208011937abc64f39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","PRLD","BK4139"],"gpt_icon":0},{"id":"2509605255","title":"Prelude Therapeutics Incorporated盘中异动 下午盘急速上涨5.41%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509605255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509605255?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:11","pubTimestamp":1738786261,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时11分，Prelude Therapeutics Incorporated股票出现异动，股价急速上涨5.41%。截至发稿，该股报1.17美元/股，成交量13.3863万股，换手率0.24%，振幅5.86%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为2.34%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206041101987bb123&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206041101987bb123&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4505","PRLD"],"gpt_icon":0},{"id":"2508996966","title":"Prelude Therapeutics Incorporated盘中异动 下午盘大幅下跌5.04%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508996966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508996966?lang=zh_cn&edition=full","pubTime":"2025-02-01 02:41","pubTimestamp":1738348906,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日02时41分，Prelude Therapeutics Incorporated股票出现异动，股价快速下跌5.04%。截至发稿，该股报1.13美元/股，成交量6.6472万股，换手率0.12%，振幅5.04%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.91%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020102414698777c38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020102414698777c38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","PRLD"],"gpt_icon":0},{"id":"2507767415","title":"Prelude Therapeutics Incorporated盘中异动 急速拉升5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507767415","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507767415?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:03","pubTimestamp":1738263808,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时03分，Prelude Therapeutics Incorporated股票出现异动，股价急速上涨5.68%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.39%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131030328a23481e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131030328a23481e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4505","PRLD"],"gpt_icon":0},{"id":"2507554304","title":"Prelude Therapeutics Incorporated盘中异动 临近午盘快速下跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507554304","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507554304?lang=zh_cn&edition=full","pubTime":"2025-01-29 00:32","pubTimestamp":1738081955,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日00时32分，Prelude Therapeutics Incorporated股票出现波动，股价急速下跌5.31%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.13%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012900323598757909&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012900323598757909&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","LENZ","BK4505","BK4139"],"gpt_icon":0},{"id":"2506307138","title":"Prelude Therapeutics Incorporated盘中异动 股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506307138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506307138?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:50","pubTimestamp":1737996616,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时50分，Prelude Therapeutics Incorporated股票出现异动，股价大幅下挫5.35%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为1.01%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012800501696124e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012800501696124e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4505","LENZ","BK4139"],"gpt_icon":0},{"id":"2506867139","title":"Prelude Therapeutics Incorporated盘中异动 大幅拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506867139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506867139?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:48","pubTimestamp":1737733726,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时48分，Prelude Therapeutics Incorporated股票出现异动，股价急速上涨5.26%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.39%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124234847a22e6c07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124234847a22e6c07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","BK4139","PRLD"],"gpt_icon":0},{"id":"2505011022","title":"Prelude Therapeutics Incorporated盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505011022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505011022?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:31","pubTimestamp":1737642664,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时31分，Prelude Therapeutics Incorporated股票出现波动，股价快速跳水5.13%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.02%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223104abb5fa36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123223104abb5fa36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRLD","LENZ","BK4505"],"gpt_icon":0},{"id":"2505721667","title":"Prelude Therapeutics Incorporated盘中异动 股价大涨5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505721667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505721667?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:37","pubTimestamp":1737556666,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时37分，Prelude Therapeutics Incorporated股票出现异动，股价大幅上涨5.72%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.12%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223746a22bb344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223746a22bb344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4139","BK4505","LENZ"],"gpt_icon":0},{"id":"2505272526","title":"Prelude Therapeutics Incorporated盘中异动 急速拉升5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505272526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505272526?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:59","pubTimestamp":1737471580,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时59分，Prelude Therapeutics Incorporated股票出现波动，股价急速上涨5.24%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为1.09%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225940960bbf15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225940960bbf15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","PRLD","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.preludetx.com","stockEarnings":[{"period":"1week","weight":0.3288},{"period":"1month","weight":0.2763},{"period":"3month","weight":0.6724},{"period":"6month","weight":1.2529},{"period":"1year","weight":1.425},{"period":"ytd","weight":0.5216}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Prelude Therapeutics Incorporated于2016年2月5日在特拉华州成立，是一家临床阶段的精密肿瘤学公司，致力于发现和开发针对高度未满足需求的癌症的关键驱动机制进行优化的小分子疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.121493},{"month":2,"riseRate":0.2,"avgChangeRate":-0.052598},{"month":3,"riseRate":0.6,"avgChangeRate":-0.08043},{"month":4,"riseRate":0.4,"avgChangeRate":-0.04002},{"month":5,"riseRate":0.2,"avgChangeRate":-0.087613},{"month":6,"riseRate":0.2,"avgChangeRate":-0.044757},{"month":7,"riseRate":0.4,"avgChangeRate":0.116264},{"month":8,"riseRate":0.6,"avgChangeRate":0.175138},{"month":9,"riseRate":0.2,"avgChangeRate":-0.157954},{"month":10,"riseRate":0.5,"avgChangeRate":-0.170878},{"month":11,"riseRate":0.5,"avgChangeRate":0.193504},{"month":12,"riseRate":0.666667,"avgChangeRate":0.137666}],"exchange":"NASDAQ","name":"Prelude Therapeutics Inc","nameEN":"Prelude Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Prelude Therapeutics Inc(PRLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Prelude Therapeutics Inc(PRLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Prelude Therapeutics Inc,PRLD,Prelude Therapeutics Inc股票,Prelude Therapeutics Inc股票老虎,Prelude Therapeutics Inc股票老虎国际,Prelude Therapeutics Inc行情,Prelude Therapeutics Inc股票行情,Prelude Therapeutics Inc股价,Prelude Therapeutics Inc股市,Prelude Therapeutics Inc股票价格,Prelude Therapeutics Inc股票交易,Prelude Therapeutics Inc股票购买,Prelude Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Prelude Therapeutics Inc(PRLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Prelude Therapeutics Inc(PRLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}